This report documents the barriers faced by transgender individuals in China who want to access gender- affirming treatments and related health care or modify their sex characteristics to accord with their sense of gender identity. With a particular focus on people’s experiences with accessing gender-affirming surgeries and hormone treatment in China’s public health system, Amnesty International found three main barriers to accessing this care: (i) a serious lack of health-related information for transgender people in China on how to access gender-affirming treatment; (ii) stringent pre-conditions to be eligible for gender-affirming surgeries; and (iii) stigma and discrimination from society, in particular family members, which makes it hard for transgender people to access and continue with gender-affirming treatments. The finding of this report is supported by existing quantitative research, including those conducted by the United National Development Programme and Peking University, on access to gender-affirming care for transgender people in China.
Related Resources
Thailand’s universal healthcare initiative now covers hormone therapy for transgender and gender-diverse Thai citizens
On the 7th of June 2026, the National Health Security Office (NHSO) of Thailand announced that Thailand’s Universal Healthcare Scheme (also known as the B30 Scheme or Gold Card), now provides Gender Affirming Healthcare to Thai transgender and gender-diverse citizens.
The...
Trans Advocacy Week Participation at the ‘Legacies of Special Rapporteur’s Health Mandate to SRHR’ 62nd HRC Side-Event
During Trans Advocacy Week of 2026, APTN’s Human Rights and Advocacy Manager, Nhuun Yodmuang, representing TAW and joined panelists of the 62nd HRC Side Event reflecting legacies of Special Rapporteur's Health Mandate to SRHR in the Past 6 Years, organised...